Olaf Mercier

机构：Université Paris-Sud, Inserm, Université Paris-Saclay, Assistance Publique – Hôpitaux de Paris, Hypertension pulmonaire : physiopathologie et innovation thérapeutique, Hôpital Marie Lannelongue, Bicêtre Hospital · ORCID：0000-0002-4760-6267

发表论文 531 篇 · 总被引 10430 次 · h-index 55

代表论文

• ISHLT Consensus Statement on the Perioperative use of ECLS in Lung Transplantation: Part III: Postoperative Considerations (2025 · The Journal of Heart and Lung Transplantation · 被引 11)
• Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group (2025 · Lung Cancer · 被引 10)
• ISHLT Consensus Statement on the Perioperative use of ECLS in Lung Transplantation: Part I: Preoperative Considerations (2025 · The Journal of Heart and Lung Transplantation · 被引 9)
• Next-generation multicenter studies: using artificial intelligence to automatically process unstructured health records of patients with lung cancer across multiple institutions (2025 · Annals of Oncology · 被引 6)
• Combination of Orai1 inhibitor CM5480 with specific therapy mitigates pulmonary hypertension and its cardiac dysfunction (2025 · JCI Insight · 被引 5)
• Ca 2+ Cycling Alteration in a Porcine Model of Right Ventricular Dysfunction (2025 · Circulation Heart Failure · 被引 5)